Checked
Retension Pharmaceuticals, Inc.
Nasdaq: RTSN · Pharmaceutical Preparations · McLean, VA
- Last filing
- 10/23/2026
- Filings on record
- 22
Company details
As reported to the SEC
- SEC CIK
- 2002988
- Stock
- Nasdaq: RTSN
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- C/O Redux Therapeutics, Llc, 902 Turkey Run Road, McLean, VA 22101
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- , Emerging growth company
- Phone
- (703) 624-2024
- Employer ID (EIN)
- 93-2592788
No annual XBRL financial data in U.S. dollars is available for this company. Funds, very new registrants, and some foreign companies that report in other currencies do not have it. See the filings below or on EDGAR.
Recent filings
22 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
| Form | Filed | Period |
|---|---|---|
| 8-KDirector or officer change | 10/23/2026 | 10/21/2026 |
| SCHEDULE 13GOwnership report (5% holder, passive) | 10/16/2026 | None |
| SCHEDULE 13GOwnership report (5% holder, passive) | 10/16/2026 | None |
| SCHEDULE 13GOwnership report (5% holder, passive) | 10/15/2026 | None |
| SCHEDULE 13DOwnership report (5% holder, active) | 10/14/2026 | None |
| S-8Registration of employee stock plan shares | 10/13/2026 | None |
| 8-KBylaws or fiscal year change | 10/13/2026 | 10/09/2026 |
| 424B4Prospectus | 10/09/2026 | None |
| EFFECTNotice of effectiveness | 10/08/2026 | None |
| CERTSEC filing | 10/08/2026 | None |
| S-1MEFSEC filing | 10/08/2026 | None |
| 8-A12BSEC filing | 10/08/2026 | None |
| S-1/ARegistration statement (amended) | 10/07/2026 | None |
| S-1/ARegistration statement (amended) | 10/05/2026 | None |
| S-1Registration statement (new securities) | 09/18/2026 | None |
| DRS/ASEC filing | 08/14/2026 | None |
| DRS/ASEC filing | 06/16/2026 | None |
| DRS/ASEC filing | 05/01/2026 | None |
| DRSSEC filing | 02/17/2026 | None |
| DNotice of exempt offering (Form D) | 05/06/2025 | None |
21 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Retension Pharmaceuticals, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Retension Pharmaceuticals, Inc.'s CIK number?
- Retension Pharmaceuticals, Inc.'s SEC Central Index Key (CIK) is 2002988.
- What is Retension Pharmaceuticals, Inc.'s stock ticker?
- Retension Pharmaceuticals, Inc. trades as Nasdaq: RTSN.
- When does Retension Pharmaceuticals, Inc.'s fiscal year end?
- Retension Pharmaceuticals, Inc.'s fiscal year end on file with the SEC is December 31.
- Where is Retension Pharmaceuticals, Inc. headquartered?
- Retension Pharmaceuticals, Inc.'s principal executive office on file with the SEC is in McLean, VA.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026